Clinical Trials Directory

Trials / Sponsors / BioInvent International AB

BioInvent International AB

Industry · 11 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Active Not RecruitingDifferent Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable
Melanoma Metastatic, Melanoma of Skin, Melanoma BRAF V600E/K Mutated
Phase 1 / Phase 22024-12-11
Active Not RecruitingBI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors
Solid Tumors, Non Small Cell Lung Cancer, Hepatocellular Carcinoma
Phase 1 / Phase 22023-12-04
TerminatedBI-1607 in Combination with Trastuzumab in Subjects with HER2-positive Advanced Solid Tumors
HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Metastatic Breast Cancer
Phase 1 / Phase 22022-07-28
RecruitingBI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D2
Advanced Malignancies, Ovarian Cancer, T-cell Lymphoma
Phase 1 / Phase 22021-01-25
RecruitingA Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Solid Tumor, Adult
Phase 1 / Phase 22020-06-29
RecruitingA Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cel
Indolent B-Cell Non-Hodgkin Lymphoma
Phase 1 / Phase 22018-05-16
TerminatedA Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple Myeloma
Multiple Myeloma
Phase 1 / Phase 22016-05-01
TerminatedA Phase II Study of BI-505 in Smoldering Multiple Myeloma
Smoldering Multiple Myeloma
Phase 22013-03-01
CompletedBioavailability Study of MLDL1278A After Subcutaneous and Intravenous Administration in Healthy Subjects
Healthy
Phase 12011-11-01
CompletedA Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myelo
Multiple Myeloma
Phase 12009-12-01
CompletedPhase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours
Solid Tumors
Phase 12008-06-01